Centrum Medyczne ENEL-MED S.A.

WSE:ENE Stock Report

Market Cap: zł571.3m

Centrum Medyczne ENEL-MED Past Earnings Performance

Past criteria checks 2/6

Centrum Medyczne ENEL-MED has been growing earnings at an average annual rate of 8.3%, while the Healthcare industry saw earnings growing at 11.1% annually. Revenues have been growing at an average rate of 10.8% per year. Centrum Medyczne ENEL-MED's return on equity is 4.3%, and it has net margins of 1%.

Key information

8.3%

Earnings growth rate

8.9%

EPS growth rate

Healthcare Industry Growth13.7%
Revenue growth rate10.8%
Return on equity4.3%
Net Margin1.0%
Last Earnings Update30 Jun 2024

Recent past performance updates

Centrum Medyczne ENEL-MED's (WSE:ENE) Solid Earnings Are Supported By Other Strong Factors

May 30
Centrum Medyczne ENEL-MED's (WSE:ENE) Solid Earnings Are Supported By Other Strong Factors

Recent updates

Centrum Medyczne ENEL-MED's (WSE:ENE) Solid Earnings Are Supported By Other Strong Factors

May 30
Centrum Medyczne ENEL-MED's (WSE:ENE) Solid Earnings Are Supported By Other Strong Factors

Calculating The Fair Value Of Centrum Medyczne ENEL-MED S.A. (WSE:ENE)

Apr 21
Calculating The Fair Value Of Centrum Medyczne ENEL-MED S.A. (WSE:ENE)

Centrum Medyczne ENEL-MED's (WSE:ENE) Returns On Capital Not Reflecting Well On The Business

May 12
Centrum Medyczne ENEL-MED's (WSE:ENE) Returns On Capital Not Reflecting Well On The Business

Is Centrum Medyczne ENEL-MED (WSE:ENE) A Risky Investment?

Jun 09
Is Centrum Medyczne ENEL-MED (WSE:ENE) A Risky Investment?

Is There More Growth In Store For Centrum Medyczne ENEL-MED's (WSE:ENE) Returns On Capital?

Feb 22
Is There More Growth In Store For Centrum Medyczne ENEL-MED's (WSE:ENE) Returns On Capital?

We Think Centrum Medyczne ENEL-MED (WSE:ENE) Can Stay On Top Of Its Debt

Feb 01
We Think Centrum Medyczne ENEL-MED (WSE:ENE) Can Stay On Top Of Its Debt

We Think Centrum Medyczne ENEL-MED's (WSE:ENE) Statutory Profit Might Understate Its Earnings Potential

Jan 11
We Think Centrum Medyczne ENEL-MED's (WSE:ENE) Statutory Profit Might Understate Its Earnings Potential

Can Mixed Fundamentals Have A Negative Impact on Centrum Medyczne ENEL-MED S.A. (WSE:ENE) Current Share Price Momentum?

Dec 21
Can Mixed Fundamentals Have A Negative Impact on Centrum Medyczne ENEL-MED S.A. (WSE:ENE) Current Share Price Momentum?

Does Centrum Medyczne ENEL-MED's (WSE:ENE) Share Price Gain of 92% Match Its Business Performance?

Nov 30
Does Centrum Medyczne ENEL-MED's (WSE:ENE) Share Price Gain of 92% Match Its Business Performance?

Revenue & Expenses Breakdown

How Centrum Medyczne ENEL-MED makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

WSE:ENE Revenue, expenses and earnings (PLN Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 246807340
31 Mar 2465416340
31 Dec 236198340
30 Sep 235897350
30 Jun 235427360
31 Mar 23522-23370
31 Dec 22495-24370
30 Sep 22476-30340
30 Jun 22476-27330
31 Mar 22450-7260
31 Dec 21441-1240
30 Sep 21427-3230
30 Jun 21419-1190
31 Mar 213984200
31 Dec 20400-3200
30 Sep 204074200
30 Jun 20410-1190
31 Mar 20424-8200
31 Dec 19418-2200
30 Sep 19406-7210
30 Jun 19393-1220
31 Mar 19382-3220
31 Dec 18372-1220
30 Sep 18360-7220
30 Jun 18350-9210
31 Mar 18338-5210
31 Dec 17324-3200
30 Sep 173092190
30 Jun 172964190
31 Mar 172853180
31 Dec 162742170
30 Sep 162651180
30 Jun 16254-1180
31 Mar 16244-2180
31 Dec 152351170
30 Sep 152262180
30 Jun 152194160
31 Mar 1521642160
31 Dec 1421442160
30 Sep 1421643140
30 Jun 1421842140
31 Mar 142124140
31 Dec 132072130

Quality Earnings: ENE has high quality earnings.

Growing Profit Margin: ENE's current net profit margins (1%) are lower than last year (1.2%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ENE has become profitable over the past 5 years, growing earnings by 8.3% per year.

Accelerating Growth: ENE's earnings growth over the past year (4.1%) is below its 5-year average (8.3% per year).

Earnings vs Industry: ENE earnings growth over the past year (4.1%) did not outperform the Healthcare industry 26.3%.


Return on Equity

High ROE: ENE's Return on Equity (4.3%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 12:35
End of Day Share Price 2024/12/23 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Centrum Medyczne ENEL-MED S.A. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sylwia JaskiewiczDom Maklerski Banku Ochrony Srodowiska S.A.
Adrian KowollikDr. Kalliwoda Research
Adrian KowollikEast Value Research GmbH